Literature DB >> 24760439

Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction.

Charles-Étienne Plourde1, Thomas Grenier-Larouche, Dominique Caron-Dorval, Simon Biron, Simon Marceau, Stéfan Lebel, Laurent Biertho, André Tchernof, Denis Richard, André C Carpentier.   

Abstract

OBJECTIVE: To assess the rapid improvement of insulin sensitivity and β-cell function following biliopancreatic diversion with duodenal switch (BPD-DS) and determine the role played by caloric restriction in these changes.
METHODS: Standard meals were administrated before and on day 3, 4, and 5 after BPD-DS to measure total caloric intake, glucose excursion, insulin sensitivity, and secretion in matched type 2 diabetes and normoglycemic (NG) subjects. In a second set of study, other subjects with type 2 diabetes had the same meal tests prior to and after a 3-day caloric restriction identical to that observed after BPD-DS and then 3 days after actually undergoing BPD-DS.
RESULTS: Improvement of HOMA-IR occurred at day 3 after BPD-DS in diabetes and after 3 days of caloric restriction. The disposition index (DI) improved rapidly in diabetes after BPD-DS and to a similar extent after caloric restriction. DI was higher and did not change after BPD-DS in NG. Changes in glucagon-like peptide-1, gastric inhibitory peptide, peptide tyrosine tyrosine, ghrelin, and pancreatic polypeptide levels were not associated with modulation of DI in the participants.
CONCLUSIONS: Caloric restriction is the major mechanism underlying the early improvement of insulin sensitivity and β-cell function after BPD-DS in type 2 diabetes.
Copyright © 2014 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760439     DOI: 10.1002/oby.20771

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  18 in total

1.  Effect of Resected Gastric Volume on Ghrelin and GLP-1 Plasma Levels: a Prospective Study.

Authors:  Federico Sista; Valentina Abruzzese; Marco Clementi; Sergio Carandina; Gianfranco Amicucci
Journal:  J Gastrointest Surg       Date:  2016-10-13       Impact factor: 3.452

2.  Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study.

Authors:  Everton Cazzo; José Carlos Pareja; Elinton Adami Chaim; Cláudio Saddy Rodrigues Coy; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

3.  Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and β-cell function.

Authors:  Julie Lacombe; Omar Al Rifai; Lorraine Loter; Thomas Moran; Anne-Frédérique Turcotte; Thomas Grenier-Larouche; André Tchernof; Laurent Biertho; André C Carpentier; Denis Prud'homme; Rémi Rabasa-Lhoret; Gerard Karsenty; Claudia Gagnon; Weiping Jiang; Mathieu Ferron
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-01-14       Impact factor: 4.310

Review 4.  Perioperative Glycemic Management of Patients Undergoing Bariatric Surgery.

Authors:  David Rometo; Mary Korytkowski
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

5.  Effects of Biliopancreatic Diversion on Bone Turnover Markers and Association with Hormonal Factors in Patients with Severe Obesity.

Authors:  Anne-Frédérique Turcotte; Thomas Grenier-Larouche; Roth-Visal Ung; David Simonyan; Anne-Marie Carreau; André C Carpentier; Fabrice Mac-Way; Laetitia Michou; André Tchernof; Laurent Biertho; Stefane Lebel; Simon Marceau; Claudia Gagnon
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

6.  Acute Changes in Non-esterified Fatty Acids in Patients with Type 2 Diabetes Receiving Bariatric Surgery.

Authors:  Reza Nemati; Jun Lu; Andrea Tura; Greg Smith; Rinki Murphy
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 7.  Bariatric surgery and obesity: influence on the incretins.

Authors:  B Laferrère
Journal:  Int J Obes Suppl       Date:  2016-11-16

8.  Targeting the gut to treat obesity and its metabolic comorbidities: focus on bariatric surgery - view from the chair.

Authors:  A C Carpentier
Journal:  Int J Obes Suppl       Date:  2016-11-16

9.  A case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.

Authors:  S J Cameron; U Daimee; R C Block
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

10.  Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function.

Authors:  Ana Carolina Junqueira Vasques; José Carlos Pareja; Maria da Saúde de Oliveira; Fernanda Satake Novaes; Marcelo Miranda Oliveira Lima; Élinton A Chaim; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Bruno Geloneze
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.